The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
Open accessAbstract
Prolactinomas in women commonly present as small intrasellar tumors, but are usually much larger in men. This discrepancy has generally been attributed to differences in the delay before diagnosis. However, studies comparing clinical and pathological correlates of growth of these tumors in both sexes are lacking. We conducted a retrospective study comparing 45 men and 51 women bearing prolactinoma to determine whether the predominance of large tumors in men was due to a delay in diagnosis or, rather, to a fundamental sex-related difference in tumor growth. Basal PRL levels (mean +/- SEM, 2789 +/- 573 ng/mL) and mean tumor diameter (26 +/- 2 mm) were significantly higher in men than in women (292 +/- 74 ng/mL and 10 +/- 1 mm, respectively; P < 0.001), but were not correlated to the age at diagnosis or the duration of symptoms. Giant tumors (n = 8) occurred in males only. The frequencies of bromocriptine-resistant tumors (30 vs.5%; P < 0.01) and invasive macroadenomas (52 vs.27%; P < 0.001) were significantly greater in men than those in women. Lastly, macroprolactinomas in males exhibited higher indexes of proliferating cells by Ki-67 immunoreactivity (2.6 +/- 1.1% of positive nuclei) than did similar tumors in female patients (0.4 +/- 0.2%; P = 0.08). We conclude that the predominance of large prolactinomas in men is due to a high frequency of rapidly growing tumors, which are often invasive and frequently bromocriptine resistant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
MOLITCH, M. E., ELTON, R. L., BLACKWELL, R. E., CALDWELL, B., CHANG, R. J., JAFFE, R., JOPLIN, G., ROBBINS, R. J., TYSON, J., & THORNER, M. O. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-698 · Cited by 435
Age‐related and gender‐related occurrence of pituitary adenomas
Mindermann, T., & Wilson, C. B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02557.x · Cited by 304
Growth rate of human pituitary adenomas
Landolt, A. M., SHIBATA, T., & Kleihues, P. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.67.6.0803 · Cited by 157
High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
St‐Jean, E., Blain, F., & Comtois, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.663486.x · Cited by 133
Miyai, K., Ichihara, K., KONDO, K., & Mori, S. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03608.x · Cited by 113
Prolactinoma in 53 men: Clinical characteristics and modes of treatment (male prolactinoma)
Berezin, M., Shimon, I., & Hadani, M. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349742 · Cited by 103
Delgrange, E., Maiter, D. M., & Donckier, J. E. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340454 · Cited by 97
Self-citationShibuya, M., Saito, F., Miwa, T., Davis, R. L., Wilson, C. B., & Hoshino, T. (1992) · Acta Neuropathologica · doi:10.1007/bf00311392 · Cited by 83
Cunnah, D., & Besser, M. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00299.x · Cited by 83
Cited by
Overview of the 2022 WHO Classification of Pituitary Tumors
Asa, S. L., Mete, O., Perry, A., & Osamura, R. Y. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09703-7 · Cited by 641
Chatzellis, E., Alexandraki, K. I., Androulakis, I. I., & Kaltsas, G. (2015) · Neuroendocrinology · doi:10.1159/000371806 · Cited by 572
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
Lopes, M. B. S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1769-8 · Cited by 548
The pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411
Self-citation
Metadata
- Authors
- Delgrange, E., Trouillas, J., Maiter, D., Donckier, J., & Tourniaire, J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-07
- Volume
- 82
- Issue
- 7
- Pages
- 2102-2107
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090071140
- Cited by
- 277
- References
- 17
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1. https://app.cochat.ai/papers/10.1210/jcem.82.7.4088
- The paper
- Delgrange, E., Trouillas, J., Maiter, D., Donckier, J., & Tourniaire, J. (1997). Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.82.7.4088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.